158 related articles for article (PubMed ID: 25853339)
1. Diacerein niosomal gel for topical delivery: development, in vitro and in vivo assessment.
El-Say KM; Abd-Allah FI; Lila AE; Hassan Ael-S; Kassem AE
J Liposome Res; 2016; 26(1):57-68. PubMed ID: 25853339
[TBL] [Abstract][Full Text] [Related]
2. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB
Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177
[TBL] [Abstract][Full Text] [Related]
3. Implementing Central Composite Design for Developing Transdermal Diacerein-Loaded Niosomes: Ex vivo Permeation and In vivo Deposition.
Aziz DE; Abdelbary AA; Elassasy AI
Curr Drug Deliv; 2018; 15(9):1330-1342. PubMed ID: 29921206
[TBL] [Abstract][Full Text] [Related]
4. Studies in topical application of niosomally entrapped Nimesulide.
Shahiwala A; Misra A
J Pharm Pharm Sci; 2002; 5(3):220-5. PubMed ID: 12553889
[TBL] [Abstract][Full Text] [Related]
5. Niosomal gel for site-specific sustained delivery of anti-arthritic drug: in vitro-in vivo evaluation.
Kaur K; Jain S; Sapra B; Tiwary AK
Curr Drug Deliv; 2007 Oct; 4(4):276-82. PubMed ID: 17979648
[TBL] [Abstract][Full Text] [Related]
6. Niosomal gel of lornoxicam for topical delivery: in vitro assessment and pharmacodynamic activity.
Kumbhar D; Wavikar P; Vavia P
AAPS PharmSciTech; 2013 Sep; 14(3):1072-82. PubMed ID: 23818079
[TBL] [Abstract][Full Text] [Related]
7. Sorbitan ester niosomes for topical delivery of rofecoxib.
Das MK; Palei NN
Indian J Exp Biol; 2011 Jun; 49(6):438-45. PubMed ID: 21702223
[TBL] [Abstract][Full Text] [Related]
8. Formulation and evaluation of meloxicam niosomes as vesicular carriers for enhanced skin delivery.
El-Menshawe SF; Hussein AK
Pharm Dev Technol; 2013; 18(4):779-86. PubMed ID: 21913880
[TBL] [Abstract][Full Text] [Related]
9. Proniosomal gel for transdermal delivery of lornoxicam: optimization using factorial design and in vivo evaluation in rats.
Shah H; Nair AB; Shah J; Bharadia P; Al-Dhubiab BE
Daru; 2019 Jun; 27(1):59-70. PubMed ID: 30701460
[TBL] [Abstract][Full Text] [Related]
10. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
[TBL] [Abstract][Full Text] [Related]
11. Optimization of methotrexate loaded niosomes by Box-Behnken design: an understanding of solvent effect and formulation variability.
Zidan AS; Mokhtar Ibrahim M; Megrab NAE
Drug Dev Ind Pharm; 2017 Sep; 43(9):1450-1459. PubMed ID: 28420295
[TBL] [Abstract][Full Text] [Related]
12. Formulation and optimization of niosomes for topical diacerein delivery using 3-factor, 3-level Box-Behnken design for the management of psoriasis.
Moghddam SR; Ahad A; Aqil M; Imam SS; Sultana Y
Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():789-97. PubMed ID: 27612773
[TBL] [Abstract][Full Text] [Related]
13. Niosome-based hydrogel of resveratrol for topical applications: An effective therapy for pain related disorder(s).
Negi P; Aggarwal M; Sharma G; Rathore C; Sharma G; Singh B; Katare OP
Biomed Pharmacother; 2017 Apr; 88():480-487. PubMed ID: 28126673
[TBL] [Abstract][Full Text] [Related]
14. Preparation and evaluation of optimized zolmitriptan niosomal emulgel.
Mohamed MI; Abdelbary AA; Kandil SM; Mahmoud TM
Drug Dev Ind Pharm; 2019 Jul; 45(7):1157-1167. PubMed ID: 30919700
[No Abstract] [Full Text] [Related]
15. Development and in-vitro characterization of sorbitan monolaurate and poloxamer 184 based niosomes for oral delivery of diacerein.
Khan MI; Madni A; Peltonen L
Eur J Pharm Sci; 2016 Dec; 95():88-95. PubMed ID: 27600819
[TBL] [Abstract][Full Text] [Related]
16. Ultrasonic Processing Technique as a Green Preparation Approach for Diacerein-Loaded Niosomes.
Khan MI; Madni A; Hirvonen J; Peltonen L
AAPS PharmSciTech; 2017 Jul; 18(5):1554-1563. PubMed ID: 27604883
[TBL] [Abstract][Full Text] [Related]
17. Date seed oil loaded niosomes: development, optimization and anti-inflammatory effect evaluation on rats.
Soliman MS; Abd-Allah FI; Hussain T; Saeed NM; El-Sawy HS
Drug Dev Ind Pharm; 2018 Jul; 44(7):1185-1197. PubMed ID: 29415582
[TBL] [Abstract][Full Text] [Related]
18. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.
Qumbar M; Ameeduzzafar ; Imam SS; Ali J; Ahmad J; Ali A
Biomed Pharmacother; 2017 Sep; 93():255-266. PubMed ID: 28738502
[TBL] [Abstract][Full Text] [Related]
19. Formulation design and optimization of novel soft glycerosomes for enhanced topical delivery of celecoxib and cupferron by Box-Behnken statistical design.
Salem HF; Kharshoum RM; Sayed OM; Abdel Hakim LF
Drug Dev Ind Pharm; 2018 Nov; 44(11):1871-1884. PubMed ID: 30044654
[TBL] [Abstract][Full Text] [Related]
20. Transdermal potential and anti-arthritic efficacy of ursolic acid from niosomal gel systems.
Jamal M; Imam SS; Aqil M; Amir M; Mir SR; Mujeeb M
Int Immunopharmacol; 2015 Dec; 29(2):361-369. PubMed ID: 26545446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
